Research Publications

• 1. Herrera AF
  2. LeBlanc M
  3. Castellino SM
  4. Li H
  5. Rutherford SC
  6. Evens AM
  7. Davison K
  8. Punnett A
  9. Parsons SK
  10. Ahmed S
  11. Casulo C
  12. Bartlett NL
  13. Tuscano JM
  14. Mei MG
  15. Hess BT
  16. Jacobs R
  17. Saeed H
  18. Torka P
  19. Hu B
  20. Moskowitz C
  21. Kaur S
  22. Goyal G
  23. Forlenza C
  24. Doan A
  25. Lamble A
  26. Kumar P
  27. Chowdhury S
  28. Brinker B
  29. Sharma N
  30. Singh A
  31. Blum KA
  32. Perry AM
  33. Kovach A
  34. Hodgson D
  35. Constine LS
  36. Shields LK
  37. Prica A
  38. Dillon H
  39. Little RF
  40. Shipp MA
  41. Crump M
  42. Kahl B
  43. Leonard JP
  44. Smith SM
  45. Song JY
  46. Kelly KM
  47. Friedberg JW
  Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.; The New England journal of medicine; Vol 391(15), pp. 1379-1389. 2024 Oct 17.
• 1. Zhao N
  2. Michelucci A
  3. Pietrangelo L
  4. Malik S
  5. Groom L
  6. Leigh J
  7. O'Connor TN
  8. Takano T
  9. Kingsley PD
  10. Palis J
  11. Boncompagni S
  12. Protasi F
  13. Dirksen RT
  An Orai1 gain-of-function tubular aggregate myopathy mouse model phenocopies key features of the human disease.; The EMBO journal. 2024 Oct 17.
• 1. Livada AC
  2. McGrath KE
  3. Malloy MW
  4. Li C
  5. Ture SK
  6. Kingsley PD
  7. Koniski AD
  8. Vit LA
  9. Nolan KE
  10. Mickelsen D
  11. Monette GE
  12. Maurya P
  13. Palis J
  14. Morrell CN
  Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models.; The Journal of clinical investigation. 2024 Sep 19.
• 1. Foley K
  2. Adlowitz DG
  3. Baker C
  4. Rock PJ
  5. Burack R
  6. Fries C
  High-throughput sequencing of archival cerebrospinal fluid specimens defines B-lymphoblastic leukemia clonal composition.; Pediatric blood & cancer. 2024 Aug 21.
• 1. Devine KA
  2. Ohman-Strickland P
  3. Barnett M
  4. Donovan KA
  5. Thompson LMA
  6. Manne SL
  7. Kearney J
  8. Levonyan-Radloff K
  9. Diaz D
  10. Dugad S
  11. Sahler OJZ
  Protocol of a Multisite Randomized Controlled Trial of Bright IDEAS-Young Adults: Problem-Solving Skills Training to Reduce Distress among Young Adults with Cancer.; Contemporary clinical trials; Vol 145, pp. 107656. 2024 Aug 05.
• 1. Palis J
  Erythropoiesis in the mammalian embryo.; Experimental hematology. 2024 Jul 22.
• 1. Constine LS
  2. Olch AJ
  3. Marks LB
  4. Jackson A
  5. Bentzen SM
  PENTEC Dedication and Acknowledgments.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 315. 2024 Jun 01.
• 1. Lucas JT
  2. Abramson ZR
  3. Epstein K
  4. Morin CE
  5. Jaju A
  6. Lee JW
  7. Lee CL
  8. Sitaram R
  9. Voss SD
  10. Hudson MM
  11. Constine LS
  12. Hua CH
  Imaging Assessment of Radiation Therapy-Related Normal Tissue Injury in Children: A PENTEC Visionary Statement.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 669-680. 2024 Jun 01.
• 1. Bentzen SM
  2. Vogelius IR
  3. Hodgson D
  4. Howell R
  5. Jackson A
  6. Hua CH
  7. Olch AJ
  8. Ronckers C
  9. Kremer L
  10. Milano M
  11. Marks LB
  12. Constine LS
  Radiation Dose-Volume-Response Relationships for Adverse Events in Childhood Cancer Survivors: Introduction to the Scientific Issues in PENTEC.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 338-353. 2024 Jun 01.
• 1. Jackson A
  2. Hua CH
  3. Olch A
  4. Yorke ED
  5. Rancati T
  6. Milano MT
  7. Constine LS
  8. Marks LB
  9. Bentzen SM
  Reporting Standards for Complication Studies of Radiation Therapy for Pediatric Cancer: Lessons From PENTEC.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 697-707. 2024 Jun 01.
• 1. Webster M
  2. Dona Lemus OM
  3. Zheng D
  4. Wancura JN
  5. Tanny S
  6. Sakthivel G
  7. Constine L
  Case study with dosimetric analysis: Total body irradiation to a patient with a left ventricular assist device.; Clinical case reports; Vol 12(5), pp. e8868. 2024 May 15.
• 1. Wyatt KD
  2. Birz S
  3. Castellino SM
  4. Henderson TO
  5. Lucas JT
  6. Pei Q
  7. Zhou Y
  8. Volchenboum SL
  9. Furner B
  10. Watkins M
  11. Kelly KM
  12. Flerlage JE
  Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL).; Journal of the National Cancer Institute; Vol 116(5), pp. 642-646. 2024 May 08.
• 1. Bowden A
  2. Zambito J
  3. El-Feghaly J
  4. Andolina JR
  Adjuvant immune checkpoint inhibitor therapy may benefit pediatric patients with stage III melanoma and sentinel lymph node positivity: a case series.; Pediatric hematology and oncology; Vol 41(6), pp. 389-398. 2024 May 07.
• 1. Binkley MS
  2. Flerlage JE
  3. Savage KJ
  4. Akhtar S
  5. Steiner R
  6. Zhang XY
  7. Dickinson M
  8. Prica A
  9. Major A
  10. Hendrickson PG
  11. Hopkins D
  12. Ng A
  13. Casulo C
  14. Baron J
  15. Roberts KB
  16. Al Kendi J
  17. Balogh A
  18. Ricardi U
  19. Torka P
  20. Specht L
  21. De Silva R
  22. Pickard K
  23. Blazin LJ
  24. Henry M
  25. Smith CM
  26. Halperin D
  27. Brady J
  28. Brennan B
  29. Senchenko MA
  30. Reeves M
  31. Hoppe BS
  32. Terezakis S
  33. Talaulikar D
  34. Picardi M
  35. Kirova Y
  36. Fergusson P
  37. Hawkes EA
  38. Lee D
  39. Doo NW
  40. Barraclough A
  41. Cheah CY
  42. Ku M
  43. Hamad N
  44. Mutsando H
  45. Gilbertson M
  46. Marconi T
  47. Viiala N
  48. Maurer MJ
  49. Eichenauer DA
  50. Hoppe RT
  International Prognostic Score for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 42(19), pp. 2271-2280. 2024 Mar 26.
• 1. Reese S
  2. Bono MH
  3. Díaz DB
  4. Donovan KA
  5. Sahler OJZ
  6. Barnett ME
  7. Levonyan-Radloff K
  8. Devine KA
  Stop and Think: A Case Study Illustrating the Implementation of Bright IDEAS-YA Being Delivered via Telehealth to a Young Adult Cancer Patient.; Journal of clinical psychology in medical settings. 2024 Mar 16.
• 1. Gorfinkel L
  2. Raghunandan S
  3. Watkins B
  4. Hebert K
  5. Neuberg DS
  6. Bratrude B
  7. Betz K
  8. Yu A
  9. Choi SW
  10. Davis J
  11. Duncan C
  12. Giller R
  13. Grimley M
  14. Harris AC
  15. Jacobsohn D
  16. Lalefar N
  17. Farhadfar N
  18. Pulsipher MA
  19. Shenoy S
  20. Petrovic A
  21. Schultz KR
  22. Yanik GA
  23. Blazar BR
  24. Horan JT
  25. Langston A
  26. Kean LS
  27. Qayed M
  Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD.; Bone marrow transplantation. 2024 Feb 21.
• 1. Williams AM
  2. Liu W
  3. Ehrhardt MJ
  4. Mirzaei Salehabadi S
  5. Panoskaltsis-Mortari A
  6. Phillips NS
  7. Mulrooney DA
  8. Flerlage JE
  9. Yasui Y
  10. Srivastava DK
  11. Robison LL
  12. Hudson MM
  13. Ness KK
  14. Sabin ND
  15. Krull KR
  Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-term Survivors of Childhood Hodgkin Lymphoma.; Clinical cancer research : an official journal of the American Association for Cancer Research. 2024 Feb 21.
• 1. Otth M
  2. Kasteler R
  3. Mulder RL
  4. Agrusa J
  5. Armenian SH
  6. Barnea D
  7. Bergeron A
  8. Bhatt NS
  9. Bourke SJ
  10. Constine LS
  11. Goutaki M
  12. Green DM
  13. Hennewig U
  14. Houdouin V
  15. Hudson MM
  16. Kremer L
  17. Latzin P
  18. Ng A
  19. Oeffinger KC
  20. Schindera C
  21. Skinner R
  22. Sommer G
  23. Srinivasan S
  24. Stokes DC
  25. Versluys B
  26. Waespe N
  27. Weiner DJ
  28. Dietz AC
  29. Kuehni CE
  Recommendations for surveillance of pulmonary dysfunction among childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.; EClinicalMedicine; Vol 69, pp. 102487. 2024 Feb 20.
• 1. Rossmann MP
  2. Palis J
  Developmental regulation of primitive erythropoiesis.; Current opinion in hematology. 2024 Feb 12.
• 1. McGrath KE
  2. Koniski AD
  3. Murphy K
  4. Getman M
  5. An HH
  6. Schulz VP
  7. Kim AR
  8. Zhang B
  9. Schofield TL
  10. Papoin J
  11. Blanc L
  12. Kingsley PD
  13. Westhoff CM
  14. Gallagher PG
  15. Chou ST
  16. Steiner LA
  17. Palis J
  BMI1 regulates human erythroid self-renewal through both gene repression and gene activation.; bioRxiv : the preprint server for biology. 2024 Feb 06.
• 1. Lo AC
  2. Liu A
  3. Liu Q
  4. Yasui Y
  5. Castellino SM
  6. Kelly KM
  7. Hererra AF
  8. Friedberg JW
  9. Friedman DL
  10. Schwartz CL
  11. Pei Q
  12. Kessel S
  13. Bergeron-Gravel S
  14. Dama H
  15. Roberts K
  16. Constine LS
  17. Hodgson DC
  Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children.; JAMA network open; Vol 7(1), pp. e2351062. 2024 Jan 02.
• 1. Milano MT
  2. Marks LB
  3. Olch AJ
  4. Yorke ED
  5. Jackson A
  6. Bentzen SM
  7. Constine LS
  Comparison of Risks of Late Effects From Radiation Therapy in Children Versus Adults: Insights From the QUANTEC, HyTEC, and PENTEC Efforts; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Nanda RH
  2. Hua CH
  3. Flampouri S
  4. Eaton B
  5. Kaste S
  6. Patni T
  7. Ronckers C
  8. Constine LS
  9. Marks LB
  10. Esiashvili N
  Risks of Spinal Abnormalities and Growth Impairment After Radiation to the Spine in Childhood Cancer Survivors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Hua CH
  2. Bentzen SM
  3. Li Y
  4. Milano MT
  5. Rancati T
  6. Marks LB
  7. Constine LS
  8. Yorke ED
  9. Jackson A
  Improving Pediatric Normal Tissue Radiation Dose-Response Modeling in Children With Cancer: A PENTEC Initiative .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Ajithkumar T
  2. Avanzo M
  3. Yorke E
  4. Tsang DS
  5. Milano MT
  6. Olch AJ
  7. Merchant TE
  8. Dieckmann K
  9. Mahajan A
  10. Fuji H
  11. Paulino AC
  12. Timmermann B
  13. Marks LB
  14. Bentzen SM
  15. Jackson A
  16. Constine LS
  Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Cooper BT
  2. Mayo CS
  3. Milano MT
  4. Olch AJ
  5. Oh C
  6. Keating GF
  7. Hallstrom A
  8. Constine LS
  9. Laack NN
  Predictive Factors Associated With Radiation Myelopathy in Pediatric Patients With Cancer: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Lo AC
  2. Liu A
  3. Liu Q
  4. Yasui Y
  5. Castellino SM
  6. Kelly KM
  7. Hererra AF
  8. Friedberg JW
  9. Friedman DL
  10. Schwartz CL
  11. Pei Q
  12. Kessel S
  13. Bergeron-Gravel S
  14. Dama H
  15. Roberts K
  16. Constine LS
  17. Hodgson DC
  Cardiac Toxicity Associated with Treatment Protocols for Hodgkin Lymphoma in Children; JAMA Network Open; Vol in press. 2024 Jan 01.
• 1. Casey DL
  2. Vogelius IR
  3. Brodin NP
  4. Roberts KB
  5. Avanzo M
  6. Moni J
  7. Owens C
  8. Ronckers CM
  9. Constine LS
  10. Bentzen SM
  11. Olch A
  Risk of subsequent neoplasms in childhood cancer survivors after radiation therapy: a comprehensive PENTEC review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Bates JE
  2. Marples B
  3. Hudson MM
  4. Williams AM
  5. Marcus K
  6. Howell R
  7. Paulino A
  8. Constine LS
  PENTEC: Biodevelopmental Considerations in Pediatric Patients with Cancer and Childhood Cancer Survivors; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Constine LS
  2. Marks LB
  3. Milano MT
  4. Ronckers CM
  5. Jackson A
  6. Hudson MM
  7. Marcus KJ
  8. Hodgson DC
  9. Hua CH
  10. Howell RM
  11. Marples B
  12. Yorke E
  13. Olch A
  14. Bentzen SM
  A User's Guide and Summary of Pediatric Normal Tissue Effects in the Clinic (PENTEC): Radiation Dose-Volume Response for Adverse Effects After Childhood Cancer Therapy and Future Directions; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Shen CJ
  2. Kry SF
  3. Buchsbaum JC
  4. Milano MT
  5. Inskip PD
  6. Ulin K
  7. Francis JH
  8. Wilson MW
  9. Whelan KF
  10. Mayo CS
  11. Olch AJ
  12. Constine LS
  13. Terezakis SA
  14. Vogelius IR
  Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 431-445. 2024 Jan 01.
• 1. Bates JE
  2. Marples B
  3. Hudson MM
  4. Williams AM
  5. Marcus K
  6. Howell R
  7. Paulino A
  8. Constine LS
  Biodevelopmental Considerations in Pediatric Patients With Cancer and Childhood Cancer Survivors: A PENTEC Introductory Review; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 354-359. 2024 Jan 01.
• 1. Constine LS
  2. Marks LB
  3. Milano MT
  4. Ronckers CM
  5. Jackson A
  6. Hudson MM
  7. Marcus KJ
  8. Hodgson DC
  9. Hua CH
  10. Howell RM
  11. Marples B
  12. Yorke E
  13. Olch A
  14. Bentzen SM
  A User's Guide and Summary of Pediatric Normal Tissue Effects in the Clinic (PENTEC): Radiation Dose-Volume Response for Adverse Effects After Childhood Cancer Therapy and Future Directions; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 321-337. 2024 Jan 01.
• 1. Milano MT
  2. Marks LB
  3. Olch AJ
  4. Yorke ED
  5. Jackson A
  6. Bentzen SM
  7. Constine LS
  Comparison of Risks of Late Effects From Radiation Therapy in Children Versus Adults: Insights From the QUANTEC, HyTEC, and PENTEC Efforts; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 387-400. 2024 Jan 01.
• 1. Hua CH
  2. Bentzen SM
  3. Li Y
  4. Milano MT
  5. Rancati T
  6. Marks LB
  7. Constine LS
  8. Yorke ED
  9. Jackson A
  Improving Pediatric Normal Tissue Radiation Dose-Response Modeling in Children With Cancer: A PENTEC Initiative; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 369-386. 2024 Jan 01.
• 1. Ajithkumar T
  2. Avanzo M
  3. Yorke E
  4. Tsang DS
  5. Milano MT
  6. Olch AJ
  7. Merchant TE
  8. Dieckmann K
  9. Mahajan A
  10. Fuji H
  11. Paulino AC
  12. Timmermann B
  13. Marks LB
  14. Bentzen SM
  15. Jackson A
  16. Constine LS
  Brain and Brain Stem Necrosis After Reirradiation for Recurrent Childhood Primary Central Nervous System Tumors: A PENTEC Comprehensive Review; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 655-668. 2024 Jan 01.
• 1. Cooper BT
  2. Mayo CS
  3. Milano MT
  4. Olch AJ
  5. Oh C
  6. Keating GF
  7. Hallstrom A
  8. Constine LS
  9. Laack NN
  Predictive Factors Associated With Radiation Myelopathy in Pediatric Patients With Cancer: A PENTEC Comprehensive Review; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 494-506. 2024 Jan 01.
• 1. Murphy B
  2. Jackson A
  3. Bass JK
  4. Tsang DS
  5. Ronckers CM
  6. Kremer L
  7. Baliga S
  8. Olch A
  9. Zureick AH
  10. Jee KW
  11. Constine LS
  12. Yock TI
  Modeling the risk of hearing loss from radiation therapy in childhood cancer survivors: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Hill-Kayser C
  2. Yorke E
  3. Jackson A
  4. Gracia C
  5. Ginsberg J
  6. Keene K
  7. Ronckers C
  8. Metzger ML
  9. Li Z
  10. Constine L
  11. Hua CH
  Effects of radiation therapy on the female reproductive tract in childhood cancer survivors: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Baliga S
  2. Patel S
  3. Naqa IE
  4. Li XA
  5. Cohen LE
  6. Howell RM
  7. Hoppe BS
  8. Constine LS
  9. Palmer JD
  10. Hamstra D
  11. Olch AJ
  Testicular dysfunction in male childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Shen CJ
  2. Kry SF
  3. Buchsbaum JC
  4. Milano MT
  5. Inskip PD
  6. Ulin K
  7. Francis JH
  8. Wilson MW
  9. Whelan KF
  10. Mayo CS
  11. Olch AJ
  12. Constine LS
  13. Terezakis SA
  14. Vogelius IR
  Retinopathy, optic neuropathy, and cataract in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Hall MD
  2. Howell RM
  3. Jackson A
  4. Owens CA
  5. Hernandez S
  6. Castellino SM
  7. Ronckers CM
  8. Constine LS
  9. Bradley JA
  Liver late effects in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Poppe MM
  2. Tai A
  3. Li XA
  4. Miften M
  5. Olch A
  6. Marks LB
  7. Qureshi BM
  8. Spunt SL
  9. Shnorhavorian M
  10. Nelson G
  11. Ronckers C
  12. Kalapurakal J
  13. Marples B
  14. Constine LS
  15. Liu AK
  Kidney disease in childhood cancer survivors treated with radiation therapy: a comprehensive PENTEC genitourinary review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Wheeler G
  2. Grassberger C
  3. Samers J
  4. Dwyer M
  5. Wiltshire K
  6. Daly P
  7. Alvarez B
  8. Campbell BA
  9. Kerr AJ
  10. Kron T
  11. Duane FK
  12. Zacharin M
  13. Downie P
  14. Kyriakou E
  15. Ronckers CM
  16. Constine LS
  17. Hiniker SM
  Central endocrine complications among childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Bates JE
  2. Rancati T
  3. Keshavarz H
  4. Gagliardi G
  5. Aznar MC
  6. Howell RM
  7. Shrestha S
  8. Moiseenko V
  9. Yorke E
  10. Armenian S
  11. Kremer L
  12. Chen MH
  13. van der PH
  14. Cutter DJ
  15. Constine LS
  16. Hodgson D
  Cardiac disease in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Ehler ED
  2. Turcotte LM
  3. Skamene S
  4. Baker KS
  5. Das SK
  6. Constine LS
  7. Yuan J
  8. Dusenbery KE
  Idiopathic pneumonitis syndrome after total body irradiation in pediatric patients undergoing myeloablative hematopoietic stem cell transplantation: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Waxer JF
  2. Wong K
  3. Modiri A
  4. Charpentier AM
  5. Moiseenko V
  6. Ronckers CM
  7. Taddei PJ
  8. Constine LS
  9. Sprow G
  10. Tamrazi B
  11. MacDonald S
  12. Olch AJ
  Risk of cerebrovascular events among childhood and adolescent patients receiving cranial radiation therapy: a Pediatric Normal Tissue Effects in the Clinic normal tissue outcomes comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Oh J
  2. Skinner L
  3. Gutkin PM
  4. Jiang A
  5. Donaldson SS
  6. Loo BJ
  7. Wang YP
  8. Ewongwo A
  9. Bredfeldt JS
  10. Breneman JC
  11. Constine LS
  12. Faught AM
  13. Haas-Kogan D
  14. Holmes JA
  15. Krasin M
  16. Larkin C
  17. Marcus KJ
  18. Maxim PG
  19. McClelland S
  20. rd MB
  21. Palmer JD
  22. Perkins SM
  23. Shen CJ
  24. Terezakis S
  25. Bush K
  26. Hiniker SM
  Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial; Advances in radiation oncology; Vol 9(10). 2024 Jan 01.
• 1. Milgrom SA
  2. van Luijk P
  3. Pino R
  4. Ronckers CM
  5. Kremer LC
  6. Gidley PW
  7. Grosshans DR
  8. Laskar S
  9. Okcu MF
  10. Constine LS
  11. Paulino AC
  Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A Pediatric Normal Tissue Effects in the Clinic (PENTEC) Comprehensive Review .; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Lo AC
  2. Ronckers C
  3. Aznar MC
  4. Avanzo M
  5. van Dijk I
  6. Kremer L
  7. Gagliardi G
  8. Howell RM
  9. Rancati T
  10. Constine LS
  11. Marcus KJ
  Breast hypoplasia and decreased lactation from radiation therapy in survivors of pediatric malignancy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Mahajan A
  2. Stavinoha PL
  3. Rongthong W
  4. Brodin NP
  5. McGovern SL
  6. El NI
  7. Palmer JD
  8. Vennarini S
  9. Indelicato DJ
  10. Aridgides P
  11. Bowers DC
  12. Kremer L
  13. Ronckers C
  14. Constine L
  15. Avanzo M
  Neurocognitive effects and necrosis in childhood cancer survivors treated with radiation therapy: a PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Briere TM
  2. Agrusa JE
  3. Martel MK
  4. Jackson A
  5. Olch AJ
  6. Ronckers CM
  7. Kremer L
  8. Constine LS
  9. McAleer MF
  Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Milano MT
  2. Vargo JA
  3. Yorke ED
  4. Ronckers CM
  5. Kremer LC
  6. Chafe S
  7. van Santen HM
  8. Marks LB
  9. Bentzen SM
  10. Constine LS
  11. Vogelius IR
  Primary hypothyroidism in childhood cancer survivors treated with radiotherapy: A PENTEC comprehensive review; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Constine LS
  2. Olch AJ
  3. Jackson A
  4. Hua CH
  5. Ronckers C
  6. Milano MT
  7. Marcus KJ
  8. Yorke E
  9. Hodgson D
  10. Howell R
  11. Hudson M
  12. Williams J
  13. Marples B
  14. Kremer L
  15. Marks LB
  16. Bentzen SM
  Pediatric Normal Tissue Effects in the Clinic (PENTEC): an international collaboration to assess normal tissue radiation dose-volume-response relationships for children with cancer; Int J Radiat Oncol Biol Phys; Vol in press. 2024 Jan 01.
• 1. Nanda RH
  2. Hua CH
  3. Flampouri S
  4. Eaton B
  5. Kaste S
  6. Patni T
  7. Ronckers C
  8. Constine LS
  9. Marks LB
  10. Esiashvili N
  Risks of Spinal Abnormalities and Growth Impairment After Radiation to the Spine in Childhood Cancer Survivors: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 507-521. 2023 Dec 08.
• 1. Murphy B
  2. Jackson A
  3. Bass JK
  4. Tsang DS
  5. Ronckers CM
  6. Kremer L
  7. Baliga S
  8. Olch A
  9. Zureick AH
  10. Jee KW
  11. Constine LS
  12. Yock TI
  Modeling the Risk of Hearing Loss From Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 446-456. 2023 Oct 19.
• 1. Hill-Kayser C
  2. Yorke E
  3. Jackson A
  4. Gracia C
  5. Ginsberg J
  6. Keene K
  7. Ronckers C
  8. Metzger ML
  9. Li Z
  10. Constine LS
  11. Hua CH
  Effects of Radiation Therapy on the Female Reproductive Tract in Childhood Cancer Survivors: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 588-609. 2023 Oct 05.
• 1. Baliga S
  2. Patel S
  3. Naqa IE
  4. Li XA
  5. Cohen LE
  6. Howell RM
  7. Hoppe BS
  8. Constine LS
  9. Palmer JD
  10. Hamstra D
  11. Olch AJ
  Testicular Dysfunction in Male Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 610-624. 2023 Oct 03.
• 1. Casey DL
  2. Vogelius IR
  3. Brodin NP
  4. Roberts KB
  5. Avanzo M
  6. Moni J
  7. Owens C
  8. Ronckers CM
  9. Constine LS
  10. Bentzen SM
  11. Olch A
  Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 640-654. 2023 Sep 29.
• 1. Lv X
  2. Murphy K
  3. Murphy Z
  4. Getman MR
  5. Rahman NF
  6. Nakamura Y
  7. Blanc L
  8. Gallagher PG
  9. Palis J
  10. Mohandas N
  11. Steiner LA
  HEXIM1 is an Essential Transcription Regulator During Human Erythropoiesis.; Blood. 2023 Sep 22.
• 1. Wang Y
  2. Ronckers CM
  3. van Leeuwen FE
  4. Moskowitz CS
  5. Leisenring W
  6. Armstrong GT
  7. de Vathaire F
  8. Hudson MM
  9. Kuehni CE
  10. Arnold MA
  11. Demoor-Goldschmidt C
  12. Green DM
  13. Henderson TO
  14. Howell RM
  15. Ehrhardt MJ
  16. Neglia JP
  17. Oeffinger KC
  18. van der Pal HJH
  19. Robison LL
  20. Schaapveld M
  21. Turcotte LM
  22. Waespe N
  23. Kremer LCM
  24. Teepen JC
  Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer.; Nature medicine; Vol 29(9), pp. 2268-2277. 2023 Sep 11.
• 1. Raghunandan S
  2. Gorfinkel L
  3. Graiser M
  4. Bratrude B
  5. Suessmuth Y
  6. Gillespie S
  7. Westbrook AL
  8. Williams KM
  9. Schoettler ML
  10. Kean LS
  11. Horan J
  12. Langston AA
  13. Qayed M
  14. Watkins B
  Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis.; Blood advances; Vol 7(16), pp. 4395-4399. 2023 Aug 22.
• 1. Goh I
  2. Botting RA
  3. Rose A
  4. Webb S
  5. Engelbert J
  6. Gitton Y
  7. Stephenson E
  8. Quiroga Londoño M
  9. Mather M
  10. Mende N
  11. Imaz-Rosshandler I
  12. Yang L
  13. Horsfall D
  14. Basurto-Lozada D
  15. Chipampe NJ
  16. Rook V
  17. Lee JTH
  18. Ton ML
  19. Keitley D
  20. Mazin P
  21. Vijayabaskar MS
  22. Hannah R
  23. Gambardella L
  24. Green K
  25. Ballereau S
  26. Inoue M
  27. Tuck E
  28. Lorenzi V
  29. Kwakwa K
  30. Alsinet C
  31. Olabi B
  32. Miah M
  33. Admane C
  34. Popescu DM
  35. Acres M
  36. Dixon D
  37. Ness T
  38. Coulthard R
  39. Lisgo S
  40. Henderson DJ
  41. Dann E
  42. Suo C
  43. Kinston SJ
  44. Park JE
  45. Polanski K
  46. Marioni J
  47. van Dongen S
  48. Meyer KB
  49. de Bruijn M
  50. Palis J
  51. Behjati S
  52. Laurenti E
  53. Wilson NK
  54. Vento-Tormo R
  55. Chédotal A
  56. Bayraktar O
  57. Roberts I
  58. Jardine L
  59. Göttgens B
  60. Teichmann SA
  61. Haniffa M
  Yolk sac cell atlas reveals multiorgan functions during human early development.; Science (New York, N.Y.); Vol 381(6659), pp. eadd7564. 2023 Aug 18.
• 1. Raghunandan S
  2. Gorfinkel L
  3. Bratrude B
  4. Suessmuth Y
  5. Hebert K
  6. Neuberg D
  7. Williams KM
  8. Schoettler ML
  9. Langston AA
  10. Kean LS
  11. Qayed M
  12. Horan J
  13. Watkins BK
  Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis.; Bone marrow transplantation. 2023 Aug 14.
• 1. Raghunandan S
  2. Qayed M
  3. Watkins BK
  4. Graiser M
  5. Gorfinkel L
  6. Westbrook A
  7. Gillespie S
  8. Bratrude B
  9. Petrovic A
  10. Suessmuth Y
  11. Horan J
  12. Kean LS
  13. Langston AA
  Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies.; Bone marrow transplantation. 2023 Aug 14.
• 1. Bourne JH
  2. Campos J
  3. Hopkin SJ
  4. Whitworth K
  5. Palis J
  6. Senis YA
  7. Rayes J
  8. Iqbal AJ
  9. Brill A
  Megakaryocyte NLRP3 hyperactivation induces mild anemia and potentiates inflammatory response in mice.; Frontiers in immunology; Vol 14, pp. 1226196. 2023 Aug 09.
• 1. Geerlinks AV
  2. Scull B
  3. Krupski C
  4. Fleischmann R
  5. Pulsipher MA
  6. Eapen M
  7. Connelly JA
  8. Bollard CM
  9. Pai SY
  10. Duncan CN
  11. Kean LS
  12. Baker KS
  13. Burroughs LM
  14. Andolina JR
  15. Shenoy S
  16. Roehrs P
  17. Hanna R
  18. Talano JA
  19. Schultz KR
  20. Stenger EO
  21. Lin H
  22. Zoref-Lorenz A
  23. McClain KL
  24. Jordan MB
  25. Man TK
  26. Allen CE
  27. Marsh RA
  Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT.; Blood advances; Vol 7(14), pp. 3725-3734. 2023 Jul 25.
• 1. Hall MD
  2. Howell RM
  3. Jackson A
  4. Owens CA
  5. Hernandez S
  6. Castellino SM
  7. Ronckers CM
  8. Constine LS
  9. Bradley JA
  Liver Late Effects in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 575-587. 2023 Jul 20.
• 1. Poppe MM
  2. Tai A
  3. Li XA
  4. Miften M
  5. Olch A
  6. Marks LB
  7. Qureshi BM
  8. Spunt SL
  9. Shnorhavorian M
  10. Nelson G
  11. Ronckers C
  12. Kalapurakal J
  13. Marples B
  14. Constine LS
  15. Liu AK
  Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 560-574. 2023 Jul 14.
• 1. Fries C
  2. Hermiston ML
  Challenging T-ALL to IL-7Rp dual inhibition.; Blood; Vol 142(2), pp. 124-126. 2023 Jul 13.
• 1. Thakar MS
  2. Logan BR
  3. Puck JM
  4. Dunn EA
  5. Buckley RH
  6. Cowan MJ
  7. O'Reilly RJ
  8. Kapoor N
  9. Satter LF
  10. Pai SY
  11. Heimall J
  12. Chandra S
  13. Ebens CL
  14. Chellapandian D
  15. Williams O
  16. Burroughs LM
  17. Saldana BD
  18. Rayes A
  19. Madden LM
  20. Chandrakasan S
  21. Bednarski JJ
  22. DeSantes KB
  23. Cuvelier GDE
  24. Teira P
  25. Gillio AP
  26. Eissa H
  27. Knutsen AP
  28. Goldman FD
  29. Aquino VM
  30. Shereck EB
  31. Moore TB
  32. Caywood EH
  33. Lugt MTV
  34. Rozmus J
  35. Broglie L
  36. Yu LC
  37. Shah AJ
  38. Andolina JR
  39. Liu X
  40. Parrott RE
  41. Dara J
  42. Prockop S
  43. Martinez CA
  44. Kapadia M
  45. Jyonouchi SC
  46. Sullivan KE
  47. Bleesing JJ
  48. Chaudhury S
  49. Petrovic A
  50. Keller MD
  51. Quigg TC
  52. Parikh S
  53. Shenoy S
  54. Seroogy C
  55. Rubin T
  56. Decaluwe H
  57. Routes JM
  58. Torgerson TR
  59. Leiding JW
  60. Pulsipher MA
  61. Kohn DB
  62. Griffith LM
  63. Haddad E
  64. Dvorak CC
  65. Notarangelo LD
  Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.; Lancet (London, England); Vol 402(10396), pp. 129-140. 2023 Jun 20.
• 1. Takahashi T
  2. Al-Kofahi M
  3. Jaber M
  4. Bratrude B
  5. Betz KM
  6. Suessmuth Y
  7. Yu A
  8. Neuberg DS
  9. Choi SW
  10. Davis JH
  11. Duncan C
  12. Giller RH
  13. Grimley M
  14. Harris AC
  15. Jacobsohn DA
  16. Lalefar NR
  17. Farhadfar N
  18. Pulsipher MA
  19. Shenoy S
  20. Petrovic A
  21. Schultz KR
  22. Yanik GA
  23. Blazar BR
  24. Horan JT
  25. Watkins B
  26. Langston A
  27. Qayed M
  28. Kean LS
  Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.; Blood. 2023 Jun 15.
• 1. Wheeler G
  2. Grassberger C
  3. Samers J
  4. Dwyer M
  5. Wiltshire K
  6. Daly P
  7. Alvarez B
  8. Campbell BA
  9. Kerr AJ
  10. Kron T
  11. Duane FK
  12. Zacharin M
  13. Downie P
  14. Kyriakou E
  15. Ronckers CM
  16. Constine LS
  17. Hiniker SM
  Central Endocrine Complications Among Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 457-466. 2023 Jun 03.
• 1. Noronha SA
  2. Strouse JJ
  Fever in Children With Sickle Cell Disease-Rethinking the Approach When Bacteremia Is Rare.; JAMA network open; Vol 6(6), pp. e2318837. 2023 Jun 01.
• 1. Stenger EO
  2. Watkins B
  3. Rogowski K
  4. Chiang KY
  5. Haight A
  6. Leung K
  7. Qayed M
  8. Raghunandan S
  9. Suessmuth Y
  10. Kean L
  11. Horan J
  Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.; Blood advances; Vol 7(10), pp. 2196-2205. 2023 May 23.
• 1. Purvis KN
  2. Swanson HD
  3. Niloy KK
  4. Zhou Y
  5. Panetta JC
  6. Crews KR
  7. Flerlage JE
  Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.; Cancer chemotherapy and pharmacology; Vol 92(1), pp. 1-6. 2023 May 18.
• 1. Devine KJ
  2. Fries C
  3. Hermiston M
  4. Wistinghausen B
  How I approach B-lymphoblastic lymphoma in children.; Pediatric blood & cancer. 2023 May 09.
• 1. Bates JE
  2. Rancati T
  3. Keshavarz H
  4. Gagliardi G
  5. Aznar MC
  6. Howell RM
  7. Shrestha S
  8. Moiseenko V
  9. Yorke E
  10. Armenian S
  11. Kremer L
  12. Chen MH
  13. van der Pal HJ
  14. Cutter DJ
  15. Constine LS
  16. Hodgson D
  Cardiac Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 522-532. 2023 Apr 14.
• 1. Ehler ED
  2. Turcotte LM
  3. Skamene S
  4. Baker KS
  5. Das SK
  6. Constine LS
  7. Yuan J
  8. Dusenbery KE
  Idiopathic Pneumonitis Syndrome After Total Body Irradiation in Pediatric Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 625-639. 2023 Mar 26.
• 1. Maurya P
  2. Ture SK
  3. Li C
  4. Scheible KM
  5. McGrath KE
  6. Palis J
  7. Morrell CN
  Transfusion of Adult, but Not Neonatal, Platelets Promotes Monocyte Trafficking in Neonatal Mice.; Arteriosclerosis, thrombosis, and vascular biology. 2023 Mar 23.
• 1. Flerlage JE
  2. Myers JR
  3. Maciaszek JL
  4. Oak N
  5. Rashkin SR
  6. Hui Y
  7. Wang YD
  8. Chen W
  9. Wu G
  10. Chang TC
  11. Hamilton K
  12. Tithi SS
  13. Goldin LR
  14. Rotunno M
  15. Caporaso N
  16. Vogt A
  17. Flamish D
  18. Wyatt K
  19. Liu J
  20. Tucker M
  21. Hahn CN
  22. Brown AL
  23. Scott HS
  24. Mullighan C
  25. Nichols KE
  26. Metzger ML
  27. McMaster ML
  28. Yang JJ
  29. Rampersaud E
  Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.; Blood; Vol 141(11), pp. 1293-1307. 2023 Mar 16.
• 1. Farris N
  2. Benoit SW
  3. McNinch NL
  4. Bodas P
  Urinary Biomarkers for the Assessment of Acute Kidney Injury of Pediatric Sickle Cell Anemia Patients Admitted for Severe Vaso-occlusive Crises.; Journal of pediatric hematology/oncology; Vol 45(6), pp. 309-314. 2023 Feb 20.
• 1. Buoninfante OA
  2. Pilzecker B
  3. Spanjaard A
  4. de Groot D
  5. Prekovic S
  6. Song JY
  7. Lieftink C
  8. Ayidah M
  9. Pritchard CEJ
  10. Vivié J
  11. Mcgrath KE
  12. Huijbers IJ
  13. Philipsen S
  14. von Lindern M
  15. Zwart W
  16. Beijersbergen RL
  17. Palis J
  18. van den Berk PCM
  19. Jacobs H
  Mammalian life depends on two distinct pathways of DNA damage tolerance.; Proceedings of the National Academy of Sciences of the United States of America; Vol 120(4), pp. e2216055120. 2023 Jan 20.
• 1. Holloway MR
  2. Fountaine T
  3. Henrichs K
  4. Feeney T
  5. Andolina J
  6. O'Dwyer K
  7. Liesveld J
  8. Blumberg N
  9. Huselton E
  Association of crystalloid fluid infusion with intravascular hemolysis and organ dysfunction in hematopoietic stem cell transplant patients.; Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2023 Jan 13.
• 1. Papoin J
  2. Yan H
  3. Leduc M
  4. Le Gall M
  5. Narla A
  6. Palis J
  7. Steiner LA
  8. Gallagher PG
  9. Hillyer CD
  10. Gautier EF
  11. Mohandas N
  12. Blanc L
  Phenotypic and proteomic characterization of the human erythroid progenitor continuum reveal dynamic changes in cell cycle and in metabolic pathways.; American journal of hematology. 2023 Jan 06.
• 1. Reilly M
  2. Dandapani SV
  3. Kumar KA
  4. Constine L
  5. Fogh SE
  6. Roberts KB
  7. Small WJ
  8. Schechter NR
  ACR-ARS practice parameter for the performance of total body irradiation; Am J Clin Oncol; Vol 46(5), pp. 185-192. 2023 Jan 01.
• 1. Gutkin PM
  2. Skinner L
  3. Jiang A
  4. Donaldson SS
  5. Loo BJ
  6. Oh J
  7. Wang YP
  8. von ER
  9. Snyder J
  10. Bredfeldt JS
  11. Breneman JC
  12. Constine LS
  13. Faught AM
  14. Haas-Kogan D
  15. Holmes JA
  16. Krasin M
  17. Larkin C
  18. Marcus KJ
  19. Maxim PG
  20. McClelland S
  21. rd MB
  22. Palmer JD
  23. Perkins SM
  24. Shen CJ
  25. Terezakis S
  26. Bush K
  27. Hiniker SM
  Feasibility of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for anesthesia avoidance in pediatric patients: a multicenter trial; Int J Radiat Oncol Biol Phys; Vol 117(1), pp. 96-104. 2023 Jan 01.
• 1. Mailhot VR
  2. Harker-Murray PD
  3. Forlenza CJ
  4. Cole P
  5. Kelly KM
  6. Milgrom SA
  7. Parikh RR
  8. Hodgson DC
  9. Castellino SM
  10. Kahn J
  11. Roberts KB
  12. Constine LS
  13. Hoppe BS
  Radiation therapy use in refractory and relapsed adolescent and young adult Hodgkin lymphoma: a report from the Children's Oncology Group; Int J Radiat Oncol Biol Phys; Vol 117(2), pp. 400-403. 2023 Jan 01.
• 1. Bates JE
  2. Shrestha S
  3. Liu Q
  4. Smith SA
  5. Mulrooney DA
  6. Leisenring W
  7. Gibson T
  8. Robison LL
  9. Chow EJ
  10. Oeffinger KC
  11. Armstrong GT
  12. Constine LS
  13. Hoppe BS
  14. Lee C
  15. Yasui Y
  16. Howell RM
  Cardiac substructure radiation dose and risk of late cardiac disease in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study; J Clin Oncol; Vol 41(22), pp. 3826-3838. 2023 Jan 01.
• 1. Chow EJ
  2. Aggarwal S
  3. Doody DR
  4. Aplenc R
  5. Armenian SH
  6. Baker KS
  7. Bhatia S
  8. Blythe N
  9. Colan SD
  10. Constine LS
  11. Freyer DR
  12. Kopp LM
  13. Laverdière C
  14. Leisenring WM
  15. Sasaki N
  16. Vrooman LM
  17. Asselin BL
  18. Schwartz CL
  19. Lipshultz SE
  Dexrazoxane and long-term heart function in survivors of childhood cancer; J Clin Oncol; Vol 41(12), pp. 2248-2257. 2023 Jan 01.
• 1. Ehrhardt MJ
  2. Leerink JM
  3. Mulder RL
  4. Mavinkurve-Groothuis A
  5. Kok W
  6. Nohria A
  7. Nathan PC
  8. Merkx R
  9. de Baat E
  10. Asogwa OA
  11. Skinner R
  12. Wallace H
  13. Lieke FE
  14. de Ville DG
  15. M PM
  16. Bárdi E
  17. Pavasovic V
  18. van der PH
  19. Fresneau B
  20. Demoor-Goldschmidt C
  21. Hennewig U
  22. Steinberger J
  23. Plummer C
  24. Chen MH
  25. Teske AJ
  26. Haddy N
  27. van Dalen EC
  28. Constine LS
  29. Chow EJ
  30. Levitt G
  31. Hudson MM
  32. Kremer L
  33. Armenian SH
  Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 24(3), pp. 108-120. 2023 Jan 01.
• 1. Cohen-Cutler S
  2. Kaplan C
  3. Olch A
  4. Wong K
  5. Malvar J
  6. Constine LS
  7. Freyer DR
  Impact of volumetric dosimetry on the projected cost of radiation-related late effects screening after childhood cancer: a real-world cohort analysis; Oncologist; Vol 28(9), pp. 784-792. 2023 Jan 01.
• 1. Bouchard EG
  2. Prince MA
  3. McCarty C
  4. Vincent PC
  5. Patel H
  6. LaValley SA
  7. Collins RL
  8. Sahler OJZ
  9. Krenz T
  10. Kelly KM
  Understanding social network support, composition, and structure among cancer caregivers.; Psycho-oncology. 2023 Jan 01.
• 1. Werk RS
  2. Koyama T
  3. Sun L
  4. Wolden S
  5. Kelly KM
  6. Constine LS
  7. Schwartz CL
  8. Friedman DL
  Post-traumatic stress symptoms in adolescent Hodgkin lymphoma survivors: a report from Children's Oncology Group AHOD0031; J Adolesc Young Adult Oncol; Vol 12(3), pp. 359-365. 2023 Jan 01.
• 1. Chow EJ
  2. Aggarwal S
  3. Doody DR
  4. Aplenc R
  5. Armenian SH
  6. Baker KS
  7. Bhatia S
  8. Blythe N
  9. Colan SD
  10. Constine LS
  11. Freyer DR
  12. Kopp LM
  13. Laverdière C
  14. Leisenring WM
  15. Sasaki N
  16. Vrooman LM
  17. Asselin BL
  18. Schwartz CL
  19. Lipshultz SE
  Dexrazoxane and long-term heart function in survivors of childhood cancer; J Clin Oncol; Vol 41(12), pp. 2248-2257. 2023 Jan 01.
• 1. Vassantachart A
  2. Olch AJ
  3. Jones M
  4. Marques C
  5. Ronckers C
  6. Constine LS
  7. Maduro JH
  8. de Boer C
  9. Wong K
  A comprehensive review of 30 years of pediatric clinical trial radiotherapy dose constraints; Pediatr Blood Cancer; Vol 70(5). 2023 Jan 01.
• 1. Kwok G
  2. Reese S
  3. Dugad S
  4. Donovan KA
  5. Tsui J
  6. Sahler OJZ
  7. Levonyan-Radloff K
  8. Barnett ME
  9. Manne S
  10. Ohman-Strickland P
  11. Devine KA
  Factors Associated with COVID‑19 Vaccine Uptake Among Adolescents and Young Adults Recently Diagnosed with Cancer.; Journal of adolescent and young adult oncology; Vol 13(2), pp. 352-357. 2022 Nov 11.
• 1. Waxer JF
  2. Wong K
  3. Modiri A
  4. Charpentier AM
  5. Moiseenko V
  6. Ronckers CM
  7. Taddei PJ
  8. Constine LS
  9. Sprow G
  10. Tamrazi B
  11. MacDonald S
  12. Olch AJ
  Risk of Cerebrovascular Events Among Childhood and Adolescent Patients Receiving Cranial Radiation Therapy: A PENTEC Normal Tissue Outcomes Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 417-430. 2022 Sep 01.
• 1. Geier CB
  2. Ellison M
  3. Cruz R
  4. Pawar S
  5. Leiss-Piller A
  6. Zmajkovicova K
  7. McNulty SM
  8. Yilmaz M
  9. Evans MO
  10. Gordon S
  11. Ujhazi B
  12. Wiest I
  13. Abolhassani H
  14. Aghamohammadi A
  15. Barmettler S
  16. Bhar S
  17. Bondarenko A
  18. Bolyard AA
  19. Buchbinder D
  20. Cada M
  21. Cavieres M
  22. Connelly JA
  23. Dale DC
  24. Deordieva E
  25. Dorsey MJ
  26. Drysdale SB
  27. Ehl S
  28. Elfeky R
  29. Fioredda F
  30. Firkin F
  31. Förster-Waldl E
  32. Geng B
  33. Goda V
  34. Gonzalez-Granado L
  35. Grunebaum E
  36. Grzesk E
  37. Henrickson SE
  38. Hilfanova A
  39. Hiwatari M
  40. Imai C
  41. Ip W
  42. Jyonouchi S
  43. Kanegane H
  44. Kawahara Y
  45. Khojah AM
  46. Kim VH
  47. Kojić M
  48. Kołtan S
  49. Krivan G
  50. Langguth D
  51. Lau YL
  52. Leung D
  53. Miano M
  54. Mersyanova I
  55. Mousallem T
  56. Muskat M
  57. Naoum FA
  58. Noronha SA
  59. Ouederni M
  60. Ozono S
  61. Richmond GW
  62. Sakovich I
  63. Salzer U
  64. Schuetz C
  65. Seeborg FO
  66. Sharapova SO
  67. Sockel K
  68. Volokha A
  69. von Bonin M
  70. Warnatz K
  71. Wegehaupt O
  72. Weinberg GA
  73. Wong KJ
  74. Worth A
  75. Yu H
  76. Zharankova Y
  77. Zhao X
  78. Devlin L
  79. Badarau A
  80. Csomos K
  81. Keszei M
  82. Pereira J
  83. Taveras AG
  84. Beaussant-Cohen SL
  85. Ong MS
  86. Shcherbina A
  87. Walter JE
  Disease Progression of WHIM Syndrome in an International Cohort of 66 Pediatric and Adult Patients.; Journal of clinical immunology. 2022 Aug 10.
• 1. Voll M
  2. Fairclough DL
  3. Morrato EH
  4. McNeal DM
  5. Embry L
  6. Pelletier W
  7. Noll RB
  8. Sahler OJZ
  Dissemination of an evidence-based behavioral intervention to alleviate distress in caregivers of children recently diagnosed with cancer: Bright IDEAS.; Pediatric blood & cancer; Vol 69(10), pp. e29904. 2022 Aug 04.
• 1. Tarlock K
  2. Sulis ML
  3. Chewning JH
  4. Pollard JA
  5. Cooper T
  6. Gamis A
  7. Shenoy S
  8. Kutny M
  9. Horan J
  10. Meshinchi S
  11. Boelens JJ
  12. Bleakley M
  13. Carpenter PA
  14. Kolb EA
  Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy.; Transplantation and cellular therapy; Vol 28(9), pp. 530-545. 2022 Jun 16.
• 1. Bouchard EG
  2. Collins RL
  3. Vincent PC
  4. Patel H
  5. Sahler O
  6. McCarty C
  7. Prince MA
  8. Kelly KM
  An initial investigation of using smartphone-enabled micro-temporal data collection to increase acceptability, feasibility, and validity of research on cancer caregiving; Pediatr Blood Cancer; Vol e29886, pp. 1-6. 2022 Jan 01.
• 1. Briere TM
  2. Agrusa JE
  3. Martel MK
  4. Jackson A
  5. Olch AJ
  6. Ronckers CM
  7. Kremer LCM
  8. Constine LS
  9. McAleer MF
  Acute and Late Pulmonary Effects After Radiation Therapy in Childhood Cancer Survivors: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 533-548. 2022 May 04.
• 1. Lo AC
  2. Major A
  3. Super L
  4. Appel B
  5. Shankar A
  6. Constine LS
  7. Marks LJ
  8. Kelly KM
  9. Metzger ML
  10. Buhtoiarov IN
  11. Mauz-Körholz C
  12. Costa ARS
  13. Binkley MS
  14. Flerlage J
  Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).; Leukemia & lymphoma; Vol 63(8), pp. 1997-2000. 2022 Mar 31.
• 1. Atkins MH
  2. Scarfò R
  3. McGrath KE
  4. Yang D
  5. Palis J
  6. Ditadi A
  7. Keller GM
  Modeling human yolk sac hematopoiesis with pluripotent stem cells.; The Journal of experimental medicine; Vol 219(3). 2022 Mar 07.
• 1. Noyes K
  2. Zapf AL
  3. Depner RN
  4. Flores T
  5. Huston A
  6. Rashid HH
  7. McNeal D
  8. Constine LS
  9. Fleming FJ
  10. Wilding GE
  11. Sahler O
  Problem-solving skills training in adult cancer survivors: Bright IDEAS-AC pilot study; Cancer Treatment and Research Communications; Vol 31, pp. 1-7. 2022 Jan 01.
• 1. Nemkov T
  2. Kingsley PD
  3. Dzieciatkowska M
  4. Malik J
  5. McGrath K
  6. Hansen KC
  7. D'Alessandro A
  8. Palis J
  Circulating primitive murine erythroblasts undergo complex proteomic and metabolomic changes during terminal maturation.; Blood advances. 2022 Feb 09.
• 1. Qayed M
  2. Watkins B
  3. Gillespie S
  4. Bratrude B
  5. Betz K
  6. Choi SW
  7. Davis J
  8. Duncan C
  9. Giller R
  10. Grimley M
  11. Harris AC
  12. Jacobsohn D
  13. Lalefar N
  14. Norkin M
  15. Farhadfar N
  16. Pulsipher MA
  17. Shenoy S
  18. Petrovic A
  19. Schultz KR
  20. Yanik GA
  21. Waller EK
  22. Langston A
  23. Kean LS
  24. Horan JT
  Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.; Blood advances; Vol 6(3), pp. 746-749. 2022 Feb 08.
• 1. Dvorak CC
  2. Haddad E
  3. Heimall J
  4. Dunn E
  5. Cowan MJ
  6. Pai SY
  7. Kapoor N
  8. Satter LF
  9. Buckley RH
  10. O'Reilly RJ
  11. Chandra S
  12. Bednarski JJ
  13. Williams O
  14. Rayes A
  15. Moore TB
  16. Ebens CL
  17. Davila Saldana BJ
  18. Petrovic A
  19. Chellapandian D
  20. Cuvelier GDE
  21. Vander Lugt MT
  22. Caywood EH
  23. Chandrakasan S
  24. Eissa H
  25. Goldman FD
  26. Shereck E
  27. Aquino VM
  28. Desantes KB
  29. Madden LM
  30. Miller HK
  31. Yu L
  32. Broglie L
  33. Gillio A
  34. Shah AJ
  35. Knutsen AP
  36. Andolina JP
  37. Joshi AY
  38. Szabolcs P
  39. Kapadia M
  40. Martinez CA
  41. Parrot RE
  42. Sullivan KE
  43. Prockop SE
  44. Abraham RS
  45. Thakar MS
  46. Leiding JW
  47. Kohn DB
  48. Pulsipher MA
  49. Griffith LM
  50. Notarangelo LD
  51. Puck JM
  The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions.; The Journal of allergy and clinical immunology. 2022 Jan 28.
• 1. Parisi R
  2. Patel RR
  3. Rood G
  4. Bowden A
  5. Turco G
  6. Korones DN
  7. Andolina JR
  8. Comito M
  9. Barth M
  10. Weintraub L
  Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients.; Pediatric blood & cancer. 2022 Jan 26.
• 1. Stenger E
  2. Xiang Y
  3. Wetzel M
  4. Gillespie S
  5. Chellapandian D
  6. Shah R
  7. Arnold SD
  8. Bhatia M
  9. Chaudhury S
  10. Eckrich MJ
  11. Kanter J
  12. Kasow KA
  13. Krajewski J
  14. Nickel RS
  15. Ngwube AI
  16. Olson TS
  17. Rangarajan HG
  18. Wobma H
  19. Guilcher GMT
  20. Horan JT
  21. Krishnamurti L
  22. Shenoy S
  23. Abraham A
  Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance.; Transplantation and cellular therapy; Vol 29(1), pp. 47.e1-47.e10. 2022 Jan 20.
• 1. Andolina JR
  2. Wang YC
  3. Ji L
  4. Freyer DR
  5. Levine JE
  6. Pulsipher MA
  7. Gamis AS
  8. Aplenc R
  9. Roth ME
  10. Harrison L
  11. Cairo MS
  Adolescent and young adult (AYA) versus pediatric patients with acute leukemia have a significantly increased risk of acute GVHD following unrelated donor (URD) stem cell transplantation (SCT): the Children's Oncology Group experience.; Bone marrow transplantation; Vol 57(3), pp. 445-452. 2022 Jan 06.
• 1. Fries C
  2. Lee LW
  3. Devidas M
  4. Dai Y
  5. Rabin KR
  6. Gupta S
  7. Loh ML
  8. Kirsch IR
  9. Wood B
  10. Rau RE
  Prognostic impact of pre-treatment immunoglobulin clonal composition in pediatric Blymphoblastic leukemia.; Haematologica. 2022 Jan 03.
• 1. Fries C
  2. Long AM
  3. Marston BA
  4. Andolina JR
  Migratory Arthralgia in a 3-year-old Girl.; Pediatrics in review; Vol 43(1), pp. 41-44. 2022 Jan 01.
• 1. Chow EJ
  2. Aplenc R
  3. Vrooman LM
  4. Doody DR
  5. Huang YV
  6. Aggarwal S
  7. Armenian SH
  8. Baker KS
  9. Bhatia S
  10. Constine LS
  11. Freyer DR
  12. Kopp LM
  13. Leisenring WM
  14. Asselin BL
  15. Schwartz CL
  16. Lipshultz SE
  Late health outcomes after dexrazoxane treatment: a report from the Children's Oncology Group; Cancer; Vol 128(4), pp. 788-796. 2022 Jan 01.
• 1. Lipshultz ER
  2. Chow EJ
  3. Doody DR
  4. Armenian SH
  5. Asselin BL
  6. Baker KS
  7. Bhatia S
  8. Constine LS
  9. Freyer DR
  10. Kopp LM
  11. Schwartz CL
  12. Lipshultz SE
  13. Vrooman LM
  Cardiometabolic risk in childhood cancer survivors: a report from the Children's Oncology Group; Cancer Epidemiol Biomarkers Prev; Vol 31(3), pp. 536-542. 2022 Jan 01.
• 1. Noyes K
  2. Zapf AL
  3. Depner RM
  4. Flores T
  5. Huston A
  6. Rashid HH
  7. McNeal D
  8. Constine LS
  9. Fleming FJ
  10. Wilding GE
  11. Sahler O
  Problem-solving skills training in adult cancer survivors: Bright IDEAS-AC pilot study; Cancer Treat Res Commun; Vol 31. 2022 Jan 01.
• 1. Marchak JG
  2. Christen S
  3. Mulder RL
  4. Baust K
  5. Blom J
  6. Brinkman TM
  7. Elens I
  8. Harju E
  9. Kadan-Lottick NS
  10. Khor J
  11. Lemiere J
  12. Recklitis CJ
  13. Wakefield CE
  14. Wiener L
  15. Constine LS
  16. Hudson MM
  17. Kremer L
  18. Skinner R
  19. Vetsch J
  20. Lee JL
  21. Michel G
  22. International GH
  23. Group PL
  24. effects G
  Recommendations for the surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 23(4), pp. 184-196. 2022 Jan 01.
• 1. Lo AC
  2. Major A
  3. Super L
  4. Appel B
  5. Shankar A
  6. Constine LS
  7. Marks LJ
  8. Kelly KM
  9. Metzger ML
  10. Buhtoiarov IN
  11. Mauz-Körholz C
  12. Costa A
  13. Binkley MS
  14. Flerlage J
  Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW); Leuk Lymphoma; Vol 63(8), pp. 1997-2000. 2022 Jan 01.
• 1. Komisarof J
  2. Lipof J
  3. DiTursi J
  4. Chowdhry A
  5. Grace CH
  6. Burack WR
  7. Constine L
  8. Passero F
  An unusual case of multiple myeloma with light-chain cast nephropathy secondary to a very large plasmacytoma without bone marrow involvement; Case Rep Hematol; Vol 2022. 2022 Jan 01.
• 1. van Iersel L
  2. Mulder RL
  3. Denzer C
  4. Cohen LE
  5. Spoudeas HA
  6. Meacham LR
  7. Sugden E
  8. Schouten-van MA
  9. Hoving EW
  10. Packer RJ
  11. Armstrong GT
  12. Mostoufi-Moab S
  13. Stades AM
  14. van Vuurden D
  15. Janssens GO
  16. Thomas-Teinturier C
  17. Murray RD
  18. Di Iorgi N
  19. Neggers S
  20. Thompson J
  21. Toogood AA
  22. Gleeson H
  23. Follin C
  24. Bardi E
  25. Torno L
  26. Patterson B
  27. Morsellino V
  28. Sommer G
  29. Clement SC
  30. Srivastava D
  31. Kiserud CE
  32. Fernandez A
  33. Scheinemann K
  34. Raman S
  35. Yuen K
  36. Wallace WH
  37. Constine LS
  38. et A
  Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors; Endocr Rev; Vol 43(5), pp. 794-823. 2022 Jan 01.
• 1. McNeal DM
  2. Sahler OJ
  3. Noll RB
  4. Fairclough DL
  5. Voll ME
  6. Bha TS
  7. Morrato EH
  Core functions and forms of Bright IDEAS: A multi-methods evaluation of the adoption of an evidence-based psychosocial training program through literative adaption; Frontiers in Health Services; Vol 96. 2022 Jan 01.
• 1. Hall MD
  2. Terezakis SA
  3. Lucas JT
  4. Gallop-Evans E
  5. Dieckmann K
  6. Constine LS
  7. Hodgson D
  8. Flerlage JE
  9. Metzger ML
  10. Hoppe BS
  Radiation Therapy Across Pediatric Hodgkin Lymphoma Research Group Protocols: A Report From the Staging, Evaluation, and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL) Group .; Int J Radiat Oncol Biol Phys; Vol 112(2), pp. 317-334. 2022 Jan 01.
• 1. Devine KA
  2. Christen S
  3. Mulder RL
  4. Brown MC
  5. Ingerski LM
  6. Mader L
  7. Potter E
  8. Sleurs C
  9. Viola A
  10. Waern S
  11. Constine LS
  12. Hudson MM
  13. Kremer L
  14. Skinner R
  15. Michel G
  16. Marchak JG
  17. Schulte F
  18. on BO
  19. the IP
  20. late EG
  Recommendations for the surveillance of education and employment outcomes in survivors of childhood, adolescent and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Cancer; Vol 128(13), pp. 2405-2419. 2022 Jan 01.
• 1. Alabdaljabar MS
  2. Durani U
  3. Thompson CA
  4. Constine LS
  5. Hashmi SK
  The forgotten survivor: A comprehensive review on Non-Hodgkin lymphoma survivorship; Am J Hematol; Vol 97(12), pp. 1627-1637. 2022 Jan 01.
• 1. Parekh A
  2. Keller FG
  3. McCarten KM
  4. Kessel S
  5. Cho S
  6. Pei Q
  7. Wu Y
  8. Castellino SM
  9. Constine LS
  10. Schwartz CL
  11. Hodgson D
  12. Kelly KM
  13. Hoppe BS
  Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis; Blood; Vol 140(10), pp. 1086-1093. 2022 Jan 01.
• 1. Stephens DM
  2. Li H
  3. Constine LS
  4. Fitzgerald TJ
  5. Leonard JP
  6. Kahl BS
  7. Song JY
  8. LeBlanc ML
  9. Smith SM
  10. Persky DO
  11. Friedberg JW
  Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001; Haematologica; Vol 107(11), pp. 2732-2736. 2022 Jan 01.
• 1. Dolgin MJ
  2. Devine KA
  3. Tzur-Bitan D
  4. Askins MA
  5. Fairclough DL
  6. Katz ER
  7. Noll RB
  8. Phipps S
  9. Sahler O
  Responsivity to Problem-Solving Skills Training in Mothers of Children with Cancer; Oxford University Press; Journal of Pediatric Psychology; Vol 46(4), pp. 413-421. 2021 Jan 01.
• 1. Eastburg L
  2. Russler-Germain DA
  3. DiPersio JF
  4. Fountaine T
  5. Andolina JR
  6. Abboud R
  7. Huselton E
  Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide.; Leukemia & lymphoma. 2021 Nov 18.
• 1. Lo AC
  2. Ronckers C
  3. Aznar MC
  4. Avanzo M
  5. van Dijk I
  6. Kremer LCM
  7. Gagliardi G
  8. Howell RM
  9. Rancati T
  10. Constine LS
  11. Marcus KJ
  Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 549-559. 2021 Oct 07.
• 1. Winter MA
  2. Greelee J
  3. Ghriwati NA
  4. Garr KN
  5. Sahler O
  Children's appraisals of threat in pediatric cancer; SSM - Mental Health 1. 2021 Jan 01.
• 1. Zhang Y
  2. McGrath KE
  3. Ayoub E
  4. Kingsley PD
  5. Yu H
  6. Fegan K
  7. McGlynn KA
  8. Rudzinskas S
  9. Palis J
  10. Perkins AS
  Mds1CreERT2, an inducible Cre allele specific to adult-repopulating hematopoietic stem cells.; Cell reports; Vol 36(7). 2021 Aug 17.
• 1. Jeffery NN
  2. Davidson C
  3. Peslak SA
  4. Kingsley PD
  5. Nakamura Y
  6. Palis J
  7. Bulger M
  Histone H2A.X phosphorylation and Caspase-Initiated Chromatin Condensation in late-stage erythropoiesis.; Epigenetics & chromatin; Vol 14(1). 2021 Jul 30.
• 1. Flerlage JE
  2. Hiniker SM
  3. Armenian S
  4. Benya EC
  5. Bobbey AJ
  6. Chang V
  7. Cooper S
  8. Coulter DW
  9. Cuglievan B
  10. Hoppe BS
  11. Isenalumhe L
  12. Kelly K
  13. Kersun L
  14. Lamble AJ
  15. Larrier NA
  16. Magee J
  17. Oduro K
  18. Pacheco M
  19. Price AP
  20. Roberts KB
  21. Smith CM
  22. Sohani AR
  23. Trovillion EM
  24. Walling E
  25. Xavier AC
  26. Burns JL
  27. Campbell M
  Pediatric Hodgkin Lymphoma, Version 3.2021.; Journal of the National Comprehensive Cancer Network : JNCCN; Vol 19(6), pp. 733-754. 2021 Jun 30.
• 1. Saunders J
  2. Niswander LM
  3. McGrath KE
  4. Koniski A
  5. Catherman SC
  6. Ture SK
  7. Medhora M
  8. Kingsley PD
  9. Calvi LM
  10. Williams JP
  11. Morrell CN
  12. Palis J
  Long-acting PGE2 and Lisinopril Mitigate H-ARS.; Radiation research. 2021 Jun 21.
• 1. Fries C
  2. Noronha SA
  3. Metlay L
  4. Zhang B
  Transplacental transfer of congenital B-cell acute lymphoblastic leukemia to the maternal vasculature.; Pediatric blood & cancer; Vol 68(9), pp. e29142. 2021 Jun 14.
• 1. Farris N
  2. Sampson M
  Single-agent rituximab for treatment of multifocal and multiple relapsed pulmonary inflammatory myofibroblastic tumor in an adolescent patient.; Pediatric blood & cancer; Vol 68(9), pp. e29131. 2021 Jun 08.
• 1. Schenone D
  2. Andolina JR
  3. Rademacher B
  4. Fountaine TJ
  5. Edwards E
  6. Nunez L
  7. Qiu M
  8. Sharma S
  9. Mullen CA
  Gene Expression and Survival of Acute Lymphoblastic Leukemia Cells After Allogeneic Transplant.; Anticancer research; Vol 41(6). 2021 Jun.
• 1. Milgrom SA
  2. van Luijk P
  3. Pino R
  4. Ronckers CM
  5. Kremer LC
  6. Gidley PW
  7. Grosshans DR
  8. Laskar S
  9. Okcu MF
  10. Constine LS
  11. Paulino AC
  Salivary and Dental Complications in Childhood Cancer Survivors Treated With Radiation Therapy to the Head and Neck: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 467-481. 2021 May 29.
• 1. Kaplan FS
  2. Teachey DT
  3. Andolina JR
  4. Siegel DM
  5. Mancilla EE
  6. Hsiao EC
  7. Al Mukaddam M
  8. Rocke DM
  9. Pignolo RJ
  Off-on-off-on use of imatinib in three children with fibrodysplasia ossificans progressiva.; Bone; Vol 150. 2021 May 19.
• 1. Fries C
  2. Girvin AR
  3. Korones DN
  4. Weintraub L
  5. Fitzpatrick L
  6. Andolina JR
  Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children.; Journal of pediatric hematology/oncology. 2021 May 18.
• 1. Casella JF
  2. Barton BA
  3. Kanter J
  4. Black LV
  5. Majumdar S
  6. Inati A
  7. Wali Y
  8. Drachtman RA
  9. Abboud MR
  10. Kilinc Y
  11. Fuh BR
  12. Al-Khabori MK
  13. Takemoto CM
  14. Salman E
  15. Sarnaik SA
  16. Shah N
  17. Morris CR
  18. Keates-Baleeiro J
  19. Raj A
  20. Alvarez OA
  21. Hsu LL
  22. Thompson AA
  23. Sisler IY
  24. Pace BS
  25. Noronha SA
  26. Lasky JL
  27. de Julian EC
  28. Godder K
  29. Thornburg CD
  30. Kamberos NL
  31. Nuss R
  32. Marsh AM
  33. Owen WC
  34. Schaefer A
  35. Tebbi CK
  36. Chantrain CF
  37. Cohen DE
  38. Karakas Z
  39. Piccone CM
  40. George A
  41. Fixler JM
  42. Singleton TC
  43. Moulton T
  44. Quinn CT
  45. de Castro Lobo CL
  46. Almomen AM
  47. Goyal-Khemka M
  48. Maes P
  49. Emanuele M
  50. Gorney RT
  51. Padgett CS
  52. Parsley E
  53. Kronsberg SS
  54. Kato GJ
  55. Gladwin MT
  Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.; JAMA; Vol 325(15), pp. 1513-1523. 2021 Apr 20.
• 1. Andolina JR
  2. Fries C
  3. Boulware R
  4. Vargas A
  5. Fraint E
  6. Barth M
  7. Abrusko S
  8. Comito M
  9. Monteleone P
  Successful Bone Marrow Transplantation With Intensive Post-transplant Intrathecal Chemotherapy for CNS Relapsed AML in 2 Infants.; Journal of pediatric hematology/oncology. 2021 Apr 09.
• 1. Mahajan A
  2. Stavinoha PL
  3. Rongthong W
  4. Brodin NP
  5. McGovern SL
  6. El Naqa I
  7. Palmer JD
  8. Vennarini S
  9. Indelicato DJ
  10. Aridgides P
  11. Bowers DC
  12. Kremer L
  13. Ronckers C
  14. Constine L
  15. Avanzo M
  Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics; Vol 119(2), pp. 401-416. 2021 Mar 30.
• 1. Milano MT
  2. Vargo JA
  3. Yorke ED
  4. Ronckers CM
  5. Kremer LC
  6. Chafe SMJ
  7. van Santen HM
  8. Marks LB
  9. Bentzen SM
  10. Constine LS
  11. Vogelius IR
  Primary Hypothyroidism in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.; International journal of radiation oncology, biology, physics. 2021 Mar 17.
• 1. Constine LS
  2. Olch AJ
  3. Jackson A
  4. Hua CH
  5. Ronckers CM
  6. Milano MT
  7. Marcus KJ
  8. Yorke E
  9. Hodgson DC
  10. Howell RM
  11. Hudson MM
  12. Williams JP
  13. Marples B
  14. C M Kremer L
  15. Marks LB
  16. Bentzen SM
  Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Assess Normal Tissue Radiation Dose-Volume-Response Relationships for Children With Cancer.; International journal of radiation oncology, biology, physics. 2021 Mar 16.
• 1. Fries C
  2. Evans AG
  3. Cheon H
  4. Korones DN
  5. Loughran TP
  6. Andolina JR
  Allogeneic Bone Marrow Transplant as a Cure for Refractory T-Cell Large Granular Lymphocytic Leukemia in an Adolescent.; Journal of pediatric hematology/oncology; Vol 44(6), pp. e960-e963. 2021 Jan 29.
• 1. Smith SM
  2. Zhang S
  3. Sundaram V
  4. Roth M
  5. Andolina JR
  6. Schapira L
  7. Sakamoto KM
  8. Kolb EA
  9. Hijiya N
  10. Chaudhury S
  Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CML.; Pediatric hematology and oncology; Vol 39(5), pp. 453-467. 2021 Jan 17.
• 1. Watkins B
  2. Qayed M
  3. McCracken C
  4. Bratrude B
  5. Betz K
  6. Suessmuth Y
  7. Yu A
  8. Sinclair S
  9. Furlan S
  10. Bosinger S
  11. Tkachev V
  12. Rhodes J
  13. Tumlin AG
  14. Narayan A
  15. Cribbin K
  16. Gillespie S
  17. Gooley TA
  18. Pasquini MC
  19. Hebert K
  20. Kapoor U
  21. Rogatko A
  22. Tighiouart M
  23. Kim S
  24. Bresee C
  25. Choi SW
  26. Davis J
  27. Duncan C
  28. Giller R
  29. Grimley M
  30. Harris AC
  31. Jacobsohn D
  32. Lalefar N
  33. Norkin M
  34. Farhadfar N
  35. Pulsipher MA
  36. Shenoy S
  37. Petrovic A
  38. Schultz KR
  39. Yanik GA
  40. Waller EK
  41. Levine JE
  42. Ferrara JL
  43. Blazar BR
  44. Langston A
  45. Horan JT
  46. Kean LS
  Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.; Journal of clinical oncology : official journal of the American Society of Clinical Oncology; Vol 39(17), pp. 1865-1877. 2021 Jan 15.
• 1. Avutu V
  2. Monga V
  3. Mittal N
  4. Saha A
  5. Andolina JR
  6. Bell DE
  7. Fair DB
  8. Flerlage JE
  9. Frediani JN
  10. Heath JL
  11. Kahn JM
  12. Reichek JL
  13. Super L
  14. Terao MA
  15. Freyer DR
  16. Roth ME
  Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network.; JCO oncology practice; Vol 18(3), pp. 224-231. 2021 Jan 14.
• 1. Tkachev V
  2. Kaminski J
  3. Potter EL
  4. Furlan SN
  5. Yu A
  6. Hunt DJ
  7. McGuckin C
  8. Zheng H
  9. Colonna L
  10. Gerdemann U
  11. Carlson J
  12. Hoffman M
  13. Olvera J
  14. English C
  15. Baldessari A
  16. Panoskaltsis-Mortari A
  17. Watkins B
  18. Qayed M
  19. Suessmuth Y
  20. Betz K
  21. Bratrude B
  22. Langston A
  23. Horan JT
  24. Ordovas-Montanes J
  25. Shalek AK
  26. Blazar BR
  27. Roederer M
  28. Kean LS
  Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.; Science translational medicine; Vol 13(576). 2021 Jan 13.
• 1. Meier ER
  2. Abraham AA
  3. Ngwube A
  4. Janson IA
  5. Guilcher GMT
  6. Horan J
  7. Kasow KA
  Hematopoietic stem cell transplant referral patterns for children with sickle cell disease vary among pediatric hematologist/oncologists' practice focus: A Sickle Cell Transplant Advocacy and Research Alliance (STAR) study.; Pediatric blood & cancer; Vol 68(3), pp. e28861. 2021 Jan 06.
• 1. McNeal DM
  2. Sahler OJ
  3. Noll RB
  4. Fairclough DL
  5. Voll ME
  6. Bha TS
  7. Morrato EH
  Evaluating the national implementation of Bright IDEAS in clinical settings: Applying the r-Aim/framework to characterize the clinical perspective.; Research Square. 2021 Jan 01.
• 1. van Atteveld JE
  2. Mulder RL
  3. van den HM
  4. Hudson MM
  5. Kremer L
  6. Skinner R
  7. Wallace WH
  8. Constine LS
  9. Higham CE
  10. Kaste SC
  11. Niinimäki R
  12. Mostoufi-Moab S
  13. Alos N
  14. Fintini D
  15. Templeton KJ
  16. Ward LM
  17. Frey E
  18. Franceschi R
  19. Pavasovic V
  20. Karol SE
  21. Amin NL
  22. Vrooman LM
  23. Harila-Saari A
  24. Demoor-Goldschmidt C
  25. Murray RD
  26. Bardi E
  27. Lequin MH
  28. Faienza MF
  29. Zaikova O
  30. Berger C
  31. Mora S
  32. Ness KK
  33. Neggers S
  34. Pluijm S
  35. Simmons JH
  36. Di Iorgi N
  Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Diabetes Endocrinol; Vol 9(9), pp. 622-637. 2021 Jan 01.
• 1. Kwiatkowski V
  2. Franco AI
  3. Cordisco MR
  4. Mullen CA
  A case of a rapidly-changing skin lesion in an 11-year-old male; Pediatrics In Review. 2021 Jan 01.
• 1. Lo AC
  2. Dieckmann K
  3. Pelz T
  4. Gallop-Evans E
  5. Engenhart-Cabillic R
  6. Vordermark D
  7. Kelly KM
  8. Schwartz CL
  9. Constine LS
  10. Roberts K
  11. Hodgson D
  Pediatric classical Hodgkin lymphoma; Pediatr Blood Cancer; Vol 68(Suppl 2). 2021 Jan 01.
• 1. Palmer JD
  2. Tsang DS
  3. Tinkle CL
  4. Olch AJ
  5. Kremer L
  6. Ronckers CM
  7. Gibbs IC
  8. Constine LS
  Late effects of radiation therapy in pediatric patients and survivorship; Pediatr Blood Cancer; Vol 68(Suppl 2). 2021 Jan 01.
• 1. van Dalen EC
  2. Mulder RL
  3. Suh E
  4. Ehrhardt MJ
  5. Aune GJ
  6. Bardi E
  7. Benson BJ
  8. Bergler-Klein J
  9. Chen MH
  10. Frey E
  11. Hennewig U
  12. Lockwood L
  13. Martinsson U
  14. Muraca M
  15. van der PH
  16. Plummer C
  17. Scheinemann K
  18. Schindera C
  19. Tonorezos ES
  20. Wallace WH
  21. Constine LS
  22. Skinner R
  23. Hudson MM
  24. Kremer L
  25. Levitt G
  26. Mulrooney DA
  Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Eur J Cancer; Vol 156, pp. 127-137. 2021 Jan 01.
• 1. Vogel J
  2. Hui S
  3. Hua CH
  4. Dusenbery K
  5. Rassiah P
  6. Kalapurakal J
  7. Constine L
  8. Esiashvili N
  Pulmonary Toxicity After Total Body Irradiation - Critical Review of the Literature and Recommendations for Toxicity Reporting; Front Oncol; Vol 11. 2021 Jan 01.
• 1. Shrestha S
  2. Bates JE
  3. Liu Q
  4. Smith SA
  5. Oeffinger KC
  6. Chow EJ
  7. Gupta AC
  8. Owens CA
  9. Constine LS
  10. Hoppe BS
  11. Leisenring WM
  12. Qiao Y
  13. Weathers RE
  14. Court LE
  15. Pinnix CC
  16. Kry SF
  17. Mulrooney DA
  18. Armstrong GT
  19. Yasui Y
  20. Howell RM
  Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study; Radiother Oncol; Vol 163, pp. 199-208. 2021 Jan 01.
• 1. Bardi E
  2. Mulder RL
  3. van Dalen EC
  4. Bhatt NS
  5. Ruble KA
  6. Burgis J
  7. Castellino SM
  8. Constine LS
  9. den HC
  10. Green DM
  11. Koot B
  12. Levitt G
  13. Szonyi L
  14. Wallace WH
  15. Skinner R
  16. Hudson MM
  17. Kremer L
  18. Effinger KE
  19. Bresters D
  Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: recommendations from the international late effects of childhood cancer guideline harmonization group.; Cancer Treat Rev; Vol 100. 2021 Jan 01.
• 1. Webster M
  2. Tanny S
  3. Joyce N
  4. Herman A
  5. Chen Y
  6. Milano M
  7. Usuki K
  8. Constine L
  9. Singh D
  10. Yeo I
  New dosimetric guidelines for linear Boltzmann transport equations through comparative evaluation of stereotactic body radiation therapy for lung treatment planning; J Appl Clin Med Phys; Vol 22(12), pp. 115-124. 2021 Jan 01.
• 1. Bates JE
  2. Chen MH
  3. Constine LS
  Radiation-Associated Coronary Disease in Young Cancer Survivors: The Beat Goes On; We Must Preserve It; JACC CardioOncol; Vol 3(3), pp. 393-396. 2021 Jan 01.
• 1. Delgadillo LF
  2. Huang YS
  3. Leon S
  4. Palis J
  5. Waugh RE
  Development of Mechanical Stability in Late-Stage Embryonic Erythroid Cells: Insights From Fluorescence Imaged Micro-Deformation Studies.; Frontiers in physiology; Vol 12. 2021.
• 1. Bowers DC
  2. Verbruggen LC
  3. Kremer L
  4. Hudson MM
  5. Skinner R
  6. Constine LS
  7. Sabin ND
  8. Bhangoo R
  9. Haupt R
  10. Hawkins MM
  11. Jenkinson H
  12. Khan RB
  13. Klimo JP
  14. Pretorius P
  15. Ng A
  16. Reulen RC
  17. Ronckers CM
  18. Sadighi Z
  19. Scheinemann K
  20. Schouten-van MN
  21. Sugden E
  22. Teepen JC
  23. Ullrich NJ
  24. Walter A
  25. Wallace WH
  26. Oeffinger KC
  27. Armstrong GT
  28. van der PH
  29. Mulder RL
  Surveillance for subsequent neoplasms of the central nervous system for childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 22(5), pp. 196-206. 2021 Jan 01.
• 1. Oeffinger KC
  2. Stratton KL
  3. Hudson MM
  4. Leisenring WM
  5. Henderson TO
  6. Howell RM
  7. Wolden SL
  8. Constine LS
  9. Diller LR
  10. Sklar CA
  11. Nathan PC
  12. Castellino SM
  13. Barnea D
  14. Smith SA
  15. Hutchinson RJ
  16. Armstrong GT
  17. Robison LL
  Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study; J Clin Oncol; Vol 39(20), pp. 2266-2275. 2021 Jan 01.
• 1. Hoppe BS
  2. Advani R
  3. Milgrom SA
  4. Bakst RL
  5. Ballas LK
  6. Dabaja BS
  7. Flowers CR
  8. Ha CS
  9. Mansur DB
  10. Metzger ML
  11. Pinnix CC
  12. Plastaras JP
  13. Roberts KB
  14. Smith SM
  15. Terezakis SA
  16. Kirwan JM
  17. Constine LS
  Primary Mediastinal B cell Lymphoma in the Positron-Emission Tomography Era: Executive Summary of the American Radium Society Appropriate Use Criteria; Int J Radiat Oncol Biol Phys; Vol 111(1), pp. 36-44. 2021 Jan 01.
• 1. Mulder RL
  2. Font-Gonzalez A
  3. Hudson MM
  4. van Santen HM
  5. Loeffen E
  6. Burns KC
  7. Quinn GP
  8. van Dulmen-den BE
  9. Byrne J
  10. Haupt R
  11. Wallace WH
  12. van den HM
  13. Anazodo A
  14. Anderson RA
  15. Barnbrock A
  16. Beck JD
  17. Bos A
  18. Demeestere I
  19. Denzer C
  20. Di Iorgi N
  21. Hoefgen HR
  22. Kebudi R
  23. Lambalk C
  24. Langer T
  25. Meacham LR
  26. Rodriguez-Wallberg K
  27. Stern C
  28. Stutz-Grunder E
  29. van Dorp W
  30. Veening M
  31. Veldkamp S
  32. van der ME
  33. Constine LS
  34. Kenney LB
  35. van de WM
  36. Kremer L
  37. Levine J
  38. Tissing W
  39. PanCareLIFE C
  Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.; Lancet Oncol; Vol 22(2), pp. 45-56. 2021 Jan 01.
• 1. Mulder RL
  2. Font-Gonzalez A
  3. Green DM
  4. Loeffen E
  5. Hudson MM
  6. Loonen J
  7. Yu R
  8. Ginsberg JP
  9. Mitchell RT
  10. Byrne J
  11. Skinner R
  12. Anazodo A
  13. Constine LS
  14. de Vries A
  15. Jahnukainen K
  16. Lorenzo A
  17. Meissner A
  18. Nahata L
  19. Dinkelman-Smit M
  20. Tournaye H
  21. Haupt R
  22. van den HM
  23. van Santen HM
  24. van Pelt A
  25. Dirksen U
  26. den HJ
  27. van Dulmen-den BE
  28. Wallace WH
  29. Levine J
  30. Tissing W
  31. Kremer L
  32. Kenney LB
  33. van de WM
  34. PanCareLIFE C
  Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group; Lancet Oncol; Vol 22(2), pp. 57-67. 2021 Jan 01.
• 1. Dorsey MJ
  2. Wright NAM
  3. Chaimowitz NS
  4. Dávila Saldaña BJ
  5. Miller H
  6. Keller MD
  7. Thakar MS
  8. Shah AJ
  9. Abu-Arja R
  10. Andolina J
  11. Aquino V
  12. Barnum JL
  13. Bednarski JJ
  14. Bhatia M
  15. Bonilla FA
  16. Butte MJ
  17. Bunin NJ
  18. Chandra S
  19. Chaudhury S
  20. Chen K
  21. Chong H
  22. Cuvelier GDE
  23. Dalal J
  24. DeFelice ML
  25. DeSantes KB
  26. Forbes LR
  27. Gillio A
  28. Goldman F
  29. Joshi AY
  30. Kapoor N
  31. Knutsen AP
  32. Kobrynski L
  33. Lieberman JA
  34. Leiding JW
  35. Oshrine B
  36. Patel KP
  37. Prockop S
  38. Quigg TC
  39. Quinones R
  40. Schultz KR
  41. Seroogy C
  42. Shyr D
  43. Siegel S
  44. Smith AR
  45. Torgerson TR
  46. Vander Lugt MT
  47. Yu LC
  48. Cowan MJ
  49. Buckley RH
  50. Dvorak CC
  51. Griffith LM
  52. Haddad E
  53. Kohn DB
  54. Logan B
  55. Notarangelo LD
  56. Pai SY
  57. Puck J
  58. Pulsipher MA
  59. Heimall J
  Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.; Journal of clinical immunology; Vol 41(1). 2021 Jan.
• 1. Kumar A
  2. Casulo C
  3. Advani RH
  4. Budde E
  5. Barr PM
  6. Batlevi CL
  7. Caron P
  8. Constine LS
  9. Dandapani SV
  10. Drill E
  11. Drullinsky P
  12. Friedberg JW
  13. Grieve C
  14. Hamilton A
  15. Hamlin PA
  16. Hoppe RT
  17. Horwitz SM
  18. Joseph A
  19. Khan N
  20. Laraque L
  21. Matasar MJ
  22. Moskowitz AJ
  23. Noy A
  24. Palomba M
  25. Schroder H
  26. Straus DJ
  27. Vemuri S
  28. Yang J
  29. Younes A
  30. Zelenetz AD
  31. Yahalom J
  32. Moskowitz CH
  Brentuximab Vedotin combined with chemotherapy in patients with newly diagnosed early-stage, unfavorable-risk Hodgkin lymphoma; J Clin Oncol; Vol 39(20), pp. 2257-2265. 2021 Jan 01.
• 1. Cohen-Cutler S
  2. Olch A
  3. Wong K
  4. Malvar J
  5. Sposto R
  6. Kobierski P
  7. Sura A
  8. Constine LS
  9. Freyer DR
  Surveillance for radiation-related late effects in childhood cancer survivors: the impact of using volumetric dosimetry; Cancer Med; Vol 10, pp. 905-913. 2021 Jan 01.
• 1. Ballas LK
  2. Metzger ML
  3. Milgrom SA
  4. Advani R
  5. Bakst RL
  6. Dabaja BS
  7. Flowers CR
  8. Ha CS
  9. Hoppe BS
  10. Mansur DB
  11. Pinnix CC
  12. Plastaras JP
  13. Roberts KB
  14. Smith SN
  15. Terezakis SA
  16. Constine LS
  Nodular lymphocyte predominant Hodgkin lymphoma: executive summary of the American Radium Society appropriate use criteria; Leuk Lymphoma; Vol 62(5), pp. 1057-1065. 2021 Jan 01.
• 1. Giulino-Roth L
  2. Pei Q
  3. Buxton A
  4. Bush R
  5. Wu Y
  6. Wolden SL
  7. Constine LS
  8. Kelly KM
  9. Schwartz CL
  10. Friedman DL
  Subsequent malignant neoplasms among children with Hodgkin lymphoma: A report from the Children's Oncology Group; Blood; Vol 137(11), pp. 1449-1456. 2021 Jan 01.
• 1. van der KA
  2. Mulder RL
  3. Hudson MM
  4. Kremer L
  5. Skinner R
  6. Constine LS
  7. van Dorp W
  8. van Dulmen-den BE
  9. Winther JF
  10. Wallace WH
  11. Waugh J
  12. Woodruff TK
  13. Anderson RA
  14. Armenian SH
  15. Bloemenkamp K
  16. Critchley H
  17. Demoor-Goldschmidt C
  18. Ehrhardt MJ
  19. Green DM
  20. Grobman WA
  21. Iwahata Y
  22. Krishna I
  23. Laven J
  24. Levitt G
  25. Meacham LR
  26. Miller ES
  27. Mulders A
  28. Polanco A
  29. Ronckers CM
  30. Samuel A
  31. Walwyn T
  32. van den HM
  33. Levine JM
  Counseling and surveillance of obstetric risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group; Am J Obstet Gynecol; Vol 224(1), pp. 3-15. 2021 Jan 01.
• 1. Palis J
  2. Yoder MC
  Endothelial Cells Transition to Blood Cells but Probably Not Back Again.; Circulation research; Vol 127(10). 2020 Oct 23.
• 1. Pariser DN
  2. Hilt ZT
  3. Ture SK
  4. Blick-Nitko SK
  5. Looney MR
  6. Cleary SJ
  7. Roman-Pagan E
  8. Saunders Ii J
  9. Georas SN
  10. Veazey JM
  11. Madere F
  12. Tesoro Santos L
  13. Arne AM
  14. Huynh NP
  15. Livada AC
  16. Guerrero-Martin SM
  17. Lyons CE
  18. Metcalf Pate KA
  19. McGrath KE
  20. Palis J
  21. Morrell C
  Lung megakaryocytes are immune modulatory cells.; The Journal of clinical investigation. 2020 Oct 20.
• 1. Fox S
  2. Myers JA
  3. Davidson C
  4. Getman M
  5. Kingsley PD
  6. Frankiewicz N
  7. Bulger M
  Hyperacetylated chromatin domains mark cell type-specific genes and suggest distinct modes of enhancer function.; Nature communications; Vol 11(1). 2020 Sep 11.
• 1. Korones DN
  Am I Racist?; The New England journal of medicine; Vol 383(12), pp. e80. 2020 Sep 01.
• 1. Phipps S
  2. Fairclough DL
  3. Noll RB
  4. Devine KA
  5. Dolgin MJ
  6. Schepers SA
  7. Askins MA
  8. Schneider NM
  9. Ingman K
  10. Voll M
  11. Katz ER
  12. McLaughlin J
  13. Sahler OJZ
  In-person vs. web-based administration of a problem-solving skills intervention for parents of children with cancer: Report of a randomized noninferiority trial.; EClinicalMedicine; Vol 24. 2020 Jul.
• 1. Devine KA
  2. Viola A
  3. Levonyan-Radloff K
  4. Mackowski N
  5. Bozzini B
  6. Chandler A
  7. Xu B
  8. Ohman-Strickland P
  9. Mayans S
  10. Farrar-Anton A
  11. Sahler OJZ
  12. Masterson M
  13. Manne S
  14. Arent S
  Feasibility of FitSurvivor: A technology-enhanced group-based fitness intervention for adolescent and young adult survivors of childhood cancer.; Pediatric blood & cancer. 2020 Jun 26.
• 1. Phipps S
  2. Fairclough DL
  3. Noll RB
  4. Devine KA
  5. Dolgin MJ
  6. Schepers SA
  7. Askins MA
  8. Schneider N
  9. lngman K
  10. Voll M
  11. Katz ER
  12. Sahler O
  In-Person vs. Online Administration of a Problem-Solving Skills Intervention for Parents of Children with Cancer: Report of a Randomized Noninferiority Trial; EClinical Medicine (Published by The Lancet); Vol 24(100428). 2020 Jan 01.
• 1. Andolina JR
  2. Walia R
  3. Oliva J
  4. Baran A
  5. Liesveld J
  6. Becker MW
  7. Busacco A
  8. Coppage M
  Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.; Hum Immunol; Vol S0198-8859(20), pp. 30318-9. 2020 Jan 01.
• 1. Dege C
  2. Fegan KH
  3. Creamer JP
  4. Berrien-Elliott MM
  5. Luff SA
  6. Kim D
  7. Wagner JA
  8. Kingsley PD
  9. McGrath KE
  10. Fehniger TA
  11. Palis J
  12. Sturgeon CM
  Potently Cytotoxic Natural Killer Cells Initially Emerge from Erythro-Myeloid Progenitors during Mammalian Development.; Developmental cell; Vol 53(2). 2020 Apr 20.
• 1. Fries C
  2. Adlowitz DG
  3. Spence JM
  4. Spence JP
  5. Rock PJ
  6. Burack WR
  Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood.; Pediatric blood & cancer. 2020 Apr 11.
• 1. Farris N
  2. Raina R
  3. Tibrewal A
  4. Brown M
  5. Colvis M
  6. Schwaderer A
  7. Kusumi K
  Acute Kidney Injury Associated With Urinary Stone Disease in Children and Young Adults Presenting to a Pediatric Emergency Department.; Frontiers in pediatrics; Vol 8, pp. 591520. 2020 Jan 30.
• 1. Buhlinger KM
  2. Borlagdan J
  3. Agegnehu B
  4. Fentie AM
  5. Bernstein AT
  6. Urick BY
  7. Roberts M
  8. Weitzman S
  9. Bekele W
  10. Korones D
  11. Alexander TB
  12. Broas J
  13. Shad A
  14. Dinkiye AM
  15. Clark SM
  16. Adam H
  17. Hailu D
  18. Muluneh B
  Results of a pre-implementation analysis of Ethiopia's National Pediatric Cancer Registry.; Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners; Vol 27(8), pp. 1940-1947. 2020 Jan 20.
• 1. Hailu D
  2. Fufu Hordofa D
  3. Adam Endalew H
  4. Karimi Mutua D
  5. Bekele W
  6. Bonilla M
  7. Çeliker MY
  8. Challinor J
  9. Dotan A
  10. Habashy C
  11. Kumar PN
  12. Rodriguez-Galindo C
  13. Wali RM
  14. Weitzman S
  15. Broas J
  16. Korones DN
  17. Alexander TB
  18. Shad AT
  Training pediatric hematologist/oncologists for capacity building in Ethiopia.; Pediatric blood & cancer; Vol 67(12), pp. e28760. 2020 Jan 13.
• 1. Cao J
  2. O'Day DR
  3. Pliner HA
  4. Kingsley PD
  5. Deng M
  6. Daza RM
  7. Zager MA
  8. Aldinger KA
  9. Blecher-Gonen R
  10. Zhang F
  11. Spielmann M
  12. Palis J
  13. Doherty D
  14. Steemers FJ
  15. Glass IA
  16. Trapnell C
  17. Shendure J
  A human cell atlas of fetal gene expression.; Science (New York, N.Y.); Vol 370(6518). 2020 Jan 13.
• 1. Shrestha S
  2. Gupta AC
  3. Bates JE
  4. Lee C
  5. Owens CA
  6. Hoppe BS
  7. Constine LS
  8. Smith SA
  9. Qiao Y
  10. Weathers RE
  11. Yasui Y
  12. Court LE
  13. Paulino AC
  14. Pinnix CC
  15. Kry SF
  16. Followill DS
  17. Armstrong GT
  18. Howell RM
  Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors; Radiother Oncol; Vol 153, pp. 163-171. 2020 Jan 01.
• 1. Mulder RL
  2. Hudson MM
  3. Bhatia S
  4. Landier W
  5. Levitt G
  6. Constine LS
  7. Wallace WH
  8. van Leeuwen FE
  9. Ronckers CM
  10. Henderson TO
  11. Moskowitz CS
  12. Friedman DN
  13. Ng AK
  14. Jenkinson HC
  15. Demoor-Goldschmidt C
  16. Skinner R
  17. Kremer L
  18. Oeffinger KC
  Updated breast cancer surveillance recommendations for female survivors of childhood, adolescent, and young adult cancer from the International Guideline Harmonization Group; J Clin Oncol; Vol 38, pp. 4194-4207. 2020 Jan 01.
• 1. Andolina JR
  StALKing Histiocytosis: ALK-positive histiocytosis identified through peripheral blood smear (in press); Acta Haematol. 2020 Jan 01.
• 1. Chow EJ
  2. Ness KK
  3. Armstrong GT
  4. Bhakta N
  5. Yeh JM
  6. Bhatia S
  7. Landier W
  8. Constine LS
  9. Hudson MM
  10. Nathan PC
  Current and coming challenges in the management of the survivorship population; Semin Oncol; Vol 47(1), pp. 23-39. 2020 Jan 01.
• 1. Chan AY
  2. Leiding JW
  3. Liu X
  4. Logan BR
  5. Burroughs LM
  6. Allenspach EJ
  7. Skoda-Smith S
  8. Uzel G
  9. Notarangelo LD
  10. Slatter M
  11. Gennery AR
  12. Smith AR
  13. Pai SY
  14. Jordan MB
  15. Marsh RA
  16. Cowan MJ
  17. Dvorak CC
  18. Craddock JA
  19. Prockop SE
  20. Chandrakasan S
  21. Kapoor N
  22. Buckley RH
  23. Parikh S
  24. Chellapandian D
  25. Oshrine BR
  26. Bednarski JJ
  27. Cooper MA
  28. Shenoy S
  29. Davila Saldana BJ
  30. Forbes LR
  31. Martinez C
  32. Haddad E
  33. Shyr DC
  34. Chen K
  35. Sullivan KE
  36. Heimall J
  37. Wright N
  38. Bhatia M
  39. Cuvelier GDE
  40. Goldman FD
  41. Meyts I
  42. Miller HK
  43. Seidel MG
  44. Vander Lugt MT
  45. Bacchetta R
  46. Weinacht KG
  47. Andolina JR
  48. Caywood E
  49. Chong H
  50. de la Morena MT
  51. Aquino VM
  52. Shereck E
  53. Walter JE
  54. Dorsey MJ
  55. Seroogy CM
  56. Griffith LM
  57. Kohn DB
  58. Puck JM
  59. Pulsipher MA
  60. Torgerson TR
  Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.; Frontiers in immunology; Vol 11. 2020.
• 1. Ehrhardt MJ
  2. Ward ZJ
  3. Liu Q
  4. Chaudhry A
  5. Nohria A
  6. Border W
  7. Fulbright JM
  8. Mulrooney DA
  9. Oeffinger KC
  10. Nathan PC
  11. Leisenring WM
  12. Constine LS
  13. Gibson TM
  14. Chow EJ
  15. Howell RM
  16. Robison LL
  17. Armstrong GT
  18. Hudson MM
  19. Diller L
  20. Yasui Y
  21. Armenian SH
  22. Yeh JM
  Cost-Effectiveness of the International Late Effects of Childhood Cancer Guideline Harmonization Group Screening Guidelines to Prevent Heart Failure in Survivors of Childhood Cancer; J Clin Oncol; Vol 38(33), pp. 3851-3862. 2020 Jan 01.
• 1. Christen S
  2. Roser K
  3. Mulder RL
  4. Ilic A
  5. Lie HC
  6. Loonen JJ
  7. Mellblom AV
  8. Kremer L
  9. Hudson MM
  10. Constine LS
  11. Skinner R
  12. Scheinemann K
  13. Gilleland MJ
  14. Michel G
  15. IGHG PL
  16. effects G
  Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.; J Cancer Surviv; Vol 14, pp. 923-938. 2020 Jan 01.

More About Pediatric Hematology Oncology Investigators

• View Investigators' Research Profiles.